Lincoln Pharmaceuticals informs about outcome of board meeting

09 Aug 2022 Evaluate
Lincoln Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held today, on Tuesday, August 9, 2022, have considered/ approved/ recommended, the followings: The un-audited financial results (standalone and consolidated) of the Company for the quarter ended on June 30, 2022 along with the limited review report from auditors thereon. In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of un-audited consolidated financial results for the quarter ended on June 30, 2022. The un-audited financial results (standalone and consolidated) will be available at Company's website at www.lincolnpharma.com. Further, it enclosed financial highlights for the aforesaid quarter; The appointment of Anand A. Patel (DIN: 00103316) as an additional and whole time director in the category of executive director of the Company with effect from August 9, 2022, subject to the approval of the Members at the ensuing AGM, in terms of provisions of Section 196, 197 and other applicable provisions of the Companies Act, 2013 and Rule framed thereunder and as per relevant regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The appointment of Samir M. Shah & Associates, Chartered Accountants (Firm Reg. No. 122377W), Ahmedabad as the statutory auditors of the Company for a period of five years from the conclusion of 28th Annual General Meeting (AGM) till the conclusion of the 33rd AGM, in place of retiring auditors and recommended for final approval of the members at the ensuing AGM; and approved the resignation tendered by Arvind G. Patel, Non-Executive Non-Independent Director of the Company from the position of Director of the Company to be made effective from August 9, 2022 after the closure of the business hours.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

480.35 -0.05 (-0.01%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×